Pay in 4 interest-free payments of $5.77 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Youre looking for a consistency that pours easily, like a light milkshake
Lancet, 361(9358), 653-661
Summary While semaglutide may cause gastrointestinal symptoms, it has significant beneficial metabolic and cardiovascular effects
Step 5: Provider evaluation and advanced management Indications for provider evaluation: Symptoms persisting despite 8 weeks of PPI therapy Symptoms that worsen over time rather than improve New-onset symptoms after months of stable treatment Any red-flag symptoms listed in the previous section Provider-directed options may include: Upper endoscopy to assess for erosive esophagitis, Barrett's esophagus, or other structural pathology 24-hour pH impedance monitoring to quantify reflux episodes Esophageal manometry to assess LES function Dose reduction (stepping down from 10 mg to 7.5 mg, for example) Medication switch (semaglutide has slightly lower reflux rates than tirzepatide in head-to-head comparisons) Treatment discontinuation if reflux is severe and refractory Foods and timing strategies that make the difference Trigger foods vary by individual, but the common offenders in GLP-1 users are: High-fat foods
